EICOSANOID METABOLISM AT THE BLOOD-BRAIN BARRIER
EICOSANOID METABOLISM AT THE BLOOD-BRAIN BARRIER
批准号:
3414358
负责人:
STEVEN A MOORE
金额:
$16.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-05-01 至 1995-04-30
中文摘要
越来越多的长链含氧多不饱和衍生物
人们在大脑中描述了脂肪酸。包括在这些项目中
化合物是前列腺素、羟基二十碳四烯酸(HETE)和
白三烯。尽管这些二十烷类化合物中的许多都能很好地调解-
以其他组织中的生理或病理生理事件为特征的,
它们在大脑的生物过程中的作用,特别是
脑血管,相对不为人所知。A数字函数具有
已经提出了从控制脑血管张力到行动
作为传递物质或细胞内第二信使,进行调解
中风、脑创伤和癫痫的病理生理事件。
我们和其他人之前已经确定了几种代谢物或花生四烯酸
离体脑微血管产生的酸和二十碳五烯酸
脑微血管内皮细胞的制备及纯化培养
和平滑肌细胞。然而,二十烷类化合物的生产
脑微血管细胞及其产生的调节,以及
这些花生四烯酸衍生物对大脑的功能影响
循环和邻近的脑实质仍不完整
特色化的。对其新陈代谢和功能知之甚少
大脑循环细胞中的omega-3脂肪酸。因此,
为了更全面地理解这一点,提出了以下目标
脑内长链多不饱和脂肪酸的生物学研究
微血管。首先,白三烯和HETE的代谢将是
在培养的脑内皮细胞和分离的脑微血管中进行了探索。
这些化合物在许多类型的脑损伤中产生,并且
潜在的病理生理介质。第二,将进行研究
为了鉴定omega-3脂肪酸的脑血管代谢物,
二十碳五烯酸和二十二碳六烯酸,这两种脂肪酸可能会阻止
或改善脑血管疾病的病理。第三,
细胞间相互作用对二十烷类化合物生物合成的调控
微血管壁、星形胶质细胞、平滑肌细胞和
内皮细胞,将进行检查。脑内皮细胞的多方面研究
分化是由星形胶质细胞和类似的
血管内皮细胞和平滑肌之间可能存在一定的联系。在……里面
此外,组成脑血管壁的细胞可能共享二十烷类化合物。
前体或中间体。最后,大脑的功能反应。
针对特定二十烷类化合物的微血管将利用
体内和体外软膜血管制剂的联合应用
血脑屏障的体外模型。二十烷类化合物有很大的潜力
作为脑血管壁内的自分泌或旁分泌化合物
并因此可能影响血管张力和血脑屏障特性。这
体外和体内方法的结合是独一无二的,应该证明
是了解大脑中二十烷类化合物生物学的有力途径
微循环。
英文摘要
A growing number of oxygenated derivatives of long chain, polyunsaturated
fatty acids are being described in the brain. Included among these
compounds are prostaglandins, hydroxyeicosatetraenoic acids (HETEs), and
leukotrienes. Although many of these eicosanoids mediate well-
characterized physiological or pathophysiological events in other tissues,
their role in the biological processes of the brain, and in particular, the
cerebral blood vessels, is relatively unknown. A number functions have
been proposed, ranging from the control of cerebrovascular tone, to action
as transmitter substances or intracellular second messengers, to mediation
of pathophysiologic events in stroke, brain trauma, and seizure.
We and others have previously identified several metabolites or arachidonic
acid and eicosapentaenoic acid produced by isolated brain microvessel
preparations and by purified cultures of cerebromicrovascular endothelium
and smooth muscle cells. Yet, the production of eicosanoids by
cerebromicrovascular cells, the regulation of their production, and the
function effects these arachidonic acid derivatives have on the cerebral
circulation and adjacent brain parenchyma remain incompletely
characterized. Even less is known about the metabolism and function of
omega-3 fatty acids in cells of the cerebral circulation. Thus, the
following aims are proposed in order to more completely understand the
biology of long chain, polyunsaturated fatty acids in cerebral
microvessels. First, the metabolism of leukotrienes and HETEs will be
explored in cultured cerebral endothelium and isolated brain microvessels.
These compounds are produced in many types of brain injury and are
potential pathophysiologic mediators. Second, studies will be undertaken
to identify the cerebrovascular metabolites of the omega-3 fatty acids,
eicosapentaenic acid and docosahexaenoic acid, fatty acids that may prevent
or ameliorate the pathology of cerebrovascular disease. Third, the
regulation of eicosanoid biosynthesis by interactions among cellular
components of the microvascular wall, astrocytes, smooth muscle cells, and
endothelium, will be examined. Many aspects of cerebral endothelial
differentiation are induced or modulated by astrocytes and similar
relationships may exist between endothelium and smooth muscle. In
addition, cells that comprise the cerebrovascular wall may share eicosanoid
precursors or intermediates. Finally, the functional responses of cerebral
microvessels to specific eicosanoids will be studied utilizing a
combination of in vivo and in vitro pial vessel preparations and an in
vitro model of the blood-brain barrier. Eicosanoids have great potential
to act as autocrine or paracrine compounds within the cerebrovascular wall
and may thus effect vascular tone and blood-brain barrier properties. This
combination of in vitro and in vivo methods is unique and should prove to
be a powerful approach to understanding eicosanoid biology in the cerebral
microcirculation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Congenital Muscular Dystrophy Workshop
-
批准号:7540571
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2008
-
负责人:STEVEN A MOORE
-
依托单位:
Muscle Biopsy/Cell Culture/Diagnostics
-
批准号:8675964
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2005
-
负责人:STEVEN A MOORE
-
依托单位:
Core B: The Muscle Tissue/Cell Repository and Specialty Diagnostics Core
-
批准号:10442634
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2005
-
负责人:STEVEN A MOORE
-
依托单位:
Muscle Biopsy/Cell Culture/Diagnostics
-
批准号:8377949
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2005
-
负责人:STEVEN A MOORE
-
依托单位:
Core--Muscle Biopsy/Cell Culture/ Diagnostics
-
批准号:6960857
-
项目类别:
-
资助金额:$26.41万
-
财政年份:2005
-
负责人:STEVEN A MOORE
-
依托单位:
Muscular Dystrophy Specialized Research Center: Core B
-
批准号:10238931
-
项目类别:
-
资助金额:$30.17万
-
财政年份:2005
-
负责人:STEVEN A MOORE
-
依托单位:
Core B: The Muscle Tissue/Cell Repository and Specialty Diagnostics Core
-
批准号:10652516
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2005
-
负责人:STEVEN A MOORE
-
依托单位:
Muscle Biopsy/Cell Culture/Diagnostics
-
批准号:8477318
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2005
-
负责人:STEVEN A MOORE
-
依托单位:
Muscular Dystrophy Cooperative Research Center
-
批准号:9306217
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2005
-
负责人:STEVEN A MOORE
-
依托单位:
Muscle Biopsy/Cell Culture/Diagnostics
-
批准号:8032689
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2005
-
负责人:STEVEN A MOORE
-
依托单位:
Muscle Biopsy/Cell Culture/Diagnostics
-
批准号:8288140
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2005
-
负责人:STEVEN A MOORE
-
依托单位:
Core--Neuropathology
-
批准号:6897085
-
项目类别:
-
资助金额:$13.96万
-
财政年份:2004
-
负责人:STEVEN A MOORE
-
依托单位:
Astrocyte dystroglycan complexes in brain development
-
批准号:6639753
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2001
-
负责人:STEVEN A MOORE
-
依托单位:
Astrocyte dystroglycan complexes in brain development
-
批准号:6540425
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2001
-
负责人:STEVEN A MOORE
-
依托单位:
Astrocyte dystroglycan complexes in brain development
-
批准号:6322569
-
项目类别:
-
资助金额:$18.02万
-
财政年份:2001
-
负责人:STEVEN A MOORE
-
依托单位:
EICOSANOID METABOLISM AT THE BLOOD BRAIN BARRIER
-
批准号:2266662
-
项目类别:
-
资助金额:$17.87万
-
财政年份:1991
-
负责人:STEVEN A MOORE
-
依托单位:
EICOSANOID METABOLISM AT THE BLOOD-BRAIN BARRIER
-
批准号:3414359
-
项目类别:
-
资助金额:$17.47万
-
财政年份:1991
-
负责人:STEVEN A MOORE
-
依托单位:
EICOSANOID METABOLISM AT THE BLOOD-BRAIN BARRIER
-
批准号:3414357
-
项目类别:
-
资助金额:$16.16万
-
财政年份:1991
-
负责人:STEVEN A MOORE
-
依托单位:
IN VITRO BLOOD BRAIN BARRIER
-
批准号:3083788
-
项目类别:
-
资助金额:$7.48万
-
财政年份:1986
-
负责人:STEVEN A MOORE
-
依托单位:
IN VITRO BLOOD BRAIN BARRIER
-
批准号:3083790
-
项目类别:
-
资助金额:$7.39万
-
财政年份:1986
-
负责人:STEVEN A MOORE
-
依托单位:
国内基金
海外基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
-
批准号:31760279
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2017
-
负责人:丁银秀
-
依托单位: